| Adam H. Schechter | President and Chief Executive Officer | FY2025 | |
| Julia A. Wang | Executive Vice President and Chief Financial Officer | FY2025 | |
| Brian J. Caveney | Executive Vice President and President, Early | FY2025 | |
| Mark S. Schroeder | Former Executive Vice President and President, Diagnostics and Chief Operations Officer | FY2022 | |
| Megan D. Bailey | Executive Vice President and President, Central Laboratories and International | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.